Narasimha Beeraka

Prof. Dr. Narasimha Beeraka

Human Anatomy and Histology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Moskva, Russia
orcid
Associate Professor, Data analyst

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2024 in Journal of Global Health
Verified
Journal Article
Open access
BZBinhua Zhu
Binhua Zhu
HGHao Gu
Hao Gu
ZMZhihan Mao
Zhihan Mao
Narasimha BeerakaNarasimha Beeraka
Narasimha Beeraka
XZXiang Zhao
Xiang Zhao
JLJunQi Liu
JunQi Liu
The incidence of gynaecological cancers (GCs) in the female reproductive system have been increasing due to improper lifestyle patterns, dietary habits, and genetic factors [1]. Gynaecological cancers (GCs) include vulvar cancer (ICD-10 C51), vaginal cancer (ICD-10 C52), cervical cancer (ICD-10 C53), uterine cancer (ICD-10 C54), ovarian cancer (ICD-10 C56), and fallopian tube cancer (ICD-10 C57.0) […]

22 December 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SDSiva Dallavalasa
Siva Dallavalasa
Narasimha BeerakaNarasimha Beeraka
Narasimha Beeraka
CBChaithanya G. Basavaraju
Chaithanya G. Basavaraju
TULIMILLI VENKATA SUBBA RAOTULIMILLI VENKATA SUBBA RAO
TULIMILLI VENKATA SUBBA RAO
SSSurya Prabha Sadhu
Surya Prabha Sadhu
SMSubbaRao V. Madhunapantula
SubbaRao V. Madhunapantula
Tumor associated macrophages (TAMs), located in the tumor microenvironment (TME), play a significant role in cancer cell survival and progression. TAMs have been involved in producing immuno-suppressive TME in the tumor by generating inflammatory mediators, growth factors, cytokines, chemokines, etc. TAMs can influence the angiogenesis, metastatic behavior of tumor cells (TCs) and cause multidrug resistance. TAMs within the TME can enhance cancer cell metastasis and are stromal and perivascular. The angiogenesis is promoted at the hypoxia, and the avascular zones of TME. Differentiation states of TAMs are considered ‘plastic’ as they exhibit temporal expression of one or several phenotypes depending on local cues. Emerging cancer research depicted the epigenetic regulation of macrophage polarization (both M1s, M2s) and their potential implications to develop pharmacologic modulators and microRNAs to act as molecular switches and even to serve as targeted therapies to inhibit tumor growth. In the present article, the role of TAMs in tumor progression, angiogenesis and metastasis was discussed. In addition, key signaling cascades regulated by TAMs, which have a role in chemoresistance, were also discussed. Currently, novel pleiotropic properties of various anticancer phytomedicines are gaining importance as they assist in overcoming TAMs-induced chemoresistance. Moreover, these phytomedicines are being tested as ‘adjunct therapeutics’ along with chemotherapeutic agents, anti-angiogenic molecules, anti-metastatic compounds, and other immune-checkpoint blockers against tumor metastasis/angiogenesis. Hence, a brief note on natural products targeting TAMs was provided. In summary, this review would benefit pharmacologists and medical professionals to develop therapies to target TAMs using multi-OMICs approaches, including genomics, epigenomics, transcriptomics, and proteomics.

1 August 2022 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
KCKuo Chen
Kuo Chen
PLPengwei Lu
Pengwei Lu
Narasimha BeerakaNarasimha Beeraka
Narasimha Beeraka
Olga SukochevaOlga Sukocheva
Olga Sukocheva
SMSubbaRao V. Madhunapantula
SubbaRao V. Madhunapantula
GAGjumrakch Aliev
Gjumrakch Aliev

26 November 2021 in Journal of Advanced Research
Verified
Journal Article
Open access
Olga SukochevaOlga Sukocheva
Olga Sukocheva
RMRebekah Maksoud
Rebekah Maksoud
Narasimha BeerakaNarasimha Beeraka
Narasimha Beeraka
SubbaRao V. MadhunapantulaSubbaRao V. Madhunapantula
SubbaRao V. Madhunapantula
MSMikhail Sinelnikov
Mikhail Sinelnikov
SMSonya Marshall-Gradisnik
Sonya Marshall-Gradisnik
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19) triggers the development of numerous pathologies and infection-linked complications and exacerbates existing pathologies in nearly all body systems. Aside from the primarily targeted respiratory organs, adverse SARS-CoV-2 effects were observed in nervous, cardiovascular, gastrointestinal/metabolic, immune, and other systems in COVID-19 survivors. Long-term effects of this viral infection have been recently observed and represent distressing sequelae recognised by the World Health Organisation (WHO) as a distinct clinical entity defined as post-COVID-19 condition. Considering the pandemic is still ongoing, more time is required to confirm post COVID-19 condition diagnosis in the COVID-19 infected cohorts, although many reported post COVID-19 symptoms overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In this study, COVID-19 clinical presentation and associated post-infection sequelae (post-COVID-19 condition) were reviewed and compared with ME/CFS symptomatology. The onset, progression, and symptom profile of post COVID-19 condition patients have considerable overlap with ME/CFS. Considering the large scope and range of pro-inflammatory effects of this virus, it is reasonable to expect development of post COVID-19 clinical complications in a proportion of the affected population. There are reports of a later debilitating syndrome onset three months post COVID-19 infection (often described as long-COVID-19), marked by the presence of fatigue, headache, cognitive dysfunction, post-exertional malaise, orthostatic intolerance, and dyspnoea. Acute inflammation, oxidative stress, and increased levels of interleukin-6 (IL-6) and tumor necrosis factor α (TNFα), have been reported in SARS-CoV-2 infected patients. Longitudinal monitoring of post COVID-19 patients is warranted to understand the long-term effects of SARS-CoV-2 infection and the pathomechanism of post COVID-19 condition.

23 August 2022 in Electronics
Verified
Journal Article
Open access
PDF file
MSManisha Singh
Manisha Singh
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
SKSethu Arun Kumar
Sethu Arun Kumar
MBMeduri Bhagyalalitha
Meduri Bhagyalalitha
HAHandattu Shankaranarayana Akshatha
Handattu Shankaranarayana Akshatha
Amir H GandomiAmir H Gandomi
Amir H Gandomi
Tuberculosis (TB) is an infectious disease that has been a major menace to human health globally, causing millions of deaths yearly. Well-timed diagnosis and treatment are an arch to full recovery of the patient. Computer-aided diagnosis (CAD) has been a hopeful choice for TB diagnosis. Many CAD approaches using machine learning have been applied for TB diagnosis, specific to the artificial intelligence (AI) domain, which has led to the resurgence of AI in the medical field. Deep learning (DL), a major branch of AI, provides bigger room for diagnosing deadly TB disease. This review is focused on the limitations of conventional TB diagnostics and a broad description of various machine learning algorithms and their applications in TB diagnosis. Furthermore, various deep learning methods integrated with other systems such as neuro-fuzzy logic, genetic algorithm, and artificial immune systems are discussed. Finally, multiple state-of-the-art tools such as CAD4TB, Lunit INSIGHT, qXR, and InferRead DR Chest are summarized to view AI-assisted future aspects in TB diagnosis.

23 December 2021 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
SKSethu Arun Kumar
Sethu Arun Kumar
TKThirumoorthy Durai Ananda Kumar
Thirumoorthy Durai Ananda Kumar
Narasimha BeerakaNarasimha Beeraka
Narasimha Beeraka
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
MSManisha Singh
Manisha Singh
MBMeduri Bhagyalalitha
Meduri Bhagyalalitha
Predicting novel small molecule bioactivities for the target deconvolution, hit-to-lead optimization in drug discovery research, requires molecular representation. Previous reports have demonstrate...